You are here: Industry Insights > COVID-19

News List

GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831) prnasia
June 30, 2021
GlaxoSmithKline Singapore and Vir Biotechnology announced an agreement with the Government of Singapore for the supply of sotrovimab, an investigational single-dose monoclonal antibody, for the treatment of patients with COVID-19 who do not require ...
Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’ pharmatimes
June 30, 2021
French pharma company Sanofi has announced that it will invest €400m into a new facility focused on solely on the development and delivery of next-generation mRNA-based vaccines.
First COVID-19 Variant Vaccine Trial Participants Vaccinated americanpharmaceuticalreview
June 30, 2021
The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 have been vaccinated to assess safety and immunogenicity in both previously vaccinated and unvaccinated adults.
Altimmune to discontinue Covid-19 vaccine programme pharmaceutical-technology
June 30, 2021
Altimmune has decided to discontinue the development of its investigational Covid-19 vaccine, AdCOVID, due to lower responses in Phase I clinical trial.
Bajaj Healthcare applies to Indian patent office for compulsory licence for Baricitinib expresspharma
June 30, 2021
Considering Bajaj Healthcare's manufacturing capabilities and strong in-house R&D team, we can produce Baricitinib at very competitive and affordable prices in India, said Anil Jain, Joint MD, Bajaj Healthcare.
2019 to 2020 Saw Drop in Number of Births in U.S. for Each Month drugs
June 30, 2021
From 2019 to 2020, there was a decrease in the number of births in the United States for each month, with declines seen for nearly all race and Hispanic-origin groups, according to a June Vital Statistics Rapid Release report.
Reported cases of myocarditis in younger men following COVID-19 vaccination are rare: Vaccination remains important, researchers stress firstwordpharma
June 30, 2021
Mayo Clinic researchers are taking a close look at rare cases of inflammation of the heart muscle, or myocarditis, in young men who developed symptoms shortly after receiving the second dose of the Moderna or Pfizer messenger RNA (mRNA) COVID-19 vaccines.
Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia firstwordpharma
June 30, 2021
Angion today announced that its exploratory Phase 2 ALI-201 trial of ANG-3777 in patients with severe COVID-19 related pneumonia at high risk for acute respiratory distress syndrome (ARDS) did not meet the primary or secondary efficacy endpoints.
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome firstwordpharma
June 30, 2021
Healthcare professionals including infectious disease physicians, family physicians, emergency room physicians, hematologists, neurologists, pharmacists, public health officials, nurses and nurse practitioners, and healthcare professionals at identified p
Human Capital Management (HCM) Solutions Market with COVID-19 Impact and Analysis | Technavio prnewswire
June 30, 2021
Set to grow by USD 11.13 billion during 2020-2024, Technavio's latest market research report estimates the human capital management (HCM) solutions market to register a CAGR of about 10%.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page